PWB
Invesco Large Cap Growth ETF · PSE
- Category Large Cap
- Expense Ratio 0.56%
- Listing Date Mar 03, 2005
- Volume 97,737.0
- Market Cap (AUM) $834.19M
Performance
+3.79%
1W
-1.34%
1M
+2.47%
3M
+24.54%
6M
+13.62%
YTD
+36.06%
1Y
Top Holdings
-
Name
Symbol%Assets
- NVIDIA CorporationNVDA4.11%
- Alphabet Inc. Class AGOOGL3.93%
- Amazon.com, Inc.AMZN3.68%
- Oracle CorporationORCL3.53%
- Broadcom Inc.AVGO3.36%
- Costco Wholesale CorporationCOST3.36%
- Eli Lilly and CompanyLLY3.33%
- Microsoft CorporationMSFT3.29%
- Netflix, Inc.NFLX3.27%
- Mastercard Incorporated Class AMA3.25%
Technical Analysis of PWB 2024-05-03
Overview:
In analyzing the technical indicators for PWB stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining key metrics such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to ...
Recent News & Updates
- 2021-11-04 03:27
- 2020-05-28 01:00
5 Reasons to Bet on Growth ETFs(Yahoo Finance)
- 2020-01-09 22:05
Why You Should Buy Growth ETFs Now(Yahoo Finance)
- 2018-01-18 21:33
What Praxairs Short Interest Suggests before 4Q17 Earnings(Marketrealist)
- 2017-12-08 03:05
4 Smart Beta ETFs for Long Term Investors(Yahoo Finance)
- 2017-10-30 02:17
Buy 5 Top-Ranked ETFs on High P/E for Further Gains(Yahoo Finance)
- 2017-10-13 00:17
- 2017-08-09 21:07
Whats Priced into Marriotts Valuation Multiple Now?(Marketrealist)
- 2017-08-09 03:05
Could Marriotts Partnership with Alibaba Be a Game Changer?(Marketrealist)
- 2017-08-06 21:09
Why Investors Should Pay Attention to Marriotts Debt Levels(Marketrealist)
- 2017-08-03 01:05
What Should We Make of Pricelines Increasing Leverage?(Marketrealist)
- 2017-07-30 21:10
Eli Lilly in 2Q17: Oncology Products Lose Revenues(Marketrealist)
- 2017-06-20 22:37
Bristol-Myers Squibb Reported Revenue Growth in 1Q17(Marketrealist)
- 2017-06-01 22:36
Performance of Eli Lillys Endocrine Products in 1Q17(Marketrealist)
- 2017-05-01 22:36
Eli Lilly & Co.s Developments in 1Q17(Marketrealist)
- 2017-04-20 00:55
4 Ways to Get Involved With Impact Investing(Investopedia)
- 2017-03-30 22:36
Exploring Eli Lillys Oncology Franchise in 2016(Marketrealist)
- 2017-03-16 19:38
A Look at Opdivos Performance in 2016(Marketrealist)
- 2017-02-26 20:06
Eli Lilly & Co.s Oncology Franchise(Marketrealist)
- 2017-01-30 02:05
Bristol-Myers Squibbs Strong Oncology Segment(Marketrealist)
- 2017-01-25 21:36
What to Expect from Eli Lillys Oncology Franchise in 4Q16(Marketrealist)
- 2017-01-17 20:55
ETFs in Focus on Robust Q4 UnitedHealth Earnings(Yahoo Finance)
- 2016-11-27 19:04
- 2016-11-25 00:04
- 2016-11-23 19:04
What You Should Know about Eli Lillys Oncology Franchise(Marketrealist)
- 2016-10-19 22:04
Eli Lilly and Co.s 3Q16 Estimates: Oncology Franchise(Marketrealist)
- 2016-10-18 22:01
Buy UnitedHealth ETFs on Upbeat Q3 Earnings(Yahoo Finance)
- 2016-10-07 01:16
Is the Dividend ETF Bull Run Over?(Yahoo Finance)
- 2016-10-04 21:42
- 2016-09-18 20:04
- 2016-09-01 23:04
- 2016-08-31 23:04
How Are Eli Lillys Business Segments Performing?(Marketrealist)
- 2016-08-23 22:04
Why Did Hormel Foods Increase Its Fiscal 2016 Guidance?(Marketrealist)
- 2016-08-22 21:30
- 2016-08-19 03:51
- 2016-08-03 21:47
Top Tech ETFs Of 2016(Yahoo Finance)
- 2016-07-26 23:57
This Seasonal ETF Is Ripe For The Pickin' This Summer(Yahoo Finance)
- 2016-07-24 21:20
A Consumer Staples ETF To Feast On(Yahoo Finance)
- 2016-07-23 00:00
- 2016-07-12 05:05
Why Are So Many Analysts Rating B&G Foods a Hold?(Marketrealist)
Page 1 of 3
previousnext